0001553610-20-000004.txt : 20200522
0001553610-20-000004.hdr.sgml : 20200522
20200522082319
ACCESSION NUMBER: 0001553610-20-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
EFFECTIVENESS DATE: 20200522
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-367515
FILM NUMBER: 20903713
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
D
1
primary_doc.xml
X0708
D
LIVE
0001389545
NovaBay Pharmaceuticals, Inc.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
(510) 899-8800
DELAWARE
NOVACAL PHARMACEUTICALS, INC.
None
Corporation
true
JUSTIN
HALL
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Executive Officer
CHIEF EXECUTIVE OFFICER
ANDREW
JONES
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Executive Officer
CHIEF FINANCIAL OFFICER
PAUL
FREIMAN
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
MIJIA (BOB)
WU
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
XINZHOU (PAUL)
LI
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
YENYOU (JEFF)
ZHENG
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
XIAOPEI (RAY)
WANG
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
SWAN
SIT
2000 POWELL STREET
SUITE 1150
EMERYVILLE
CA
CALIFORNIA
94608
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-05-13
false
true
true
false
0
1731030
1030
1730000
SEE THE DESCRIPTION OF THE SERVICES AGREEMENT REGARDING THE WARRANTS TO BE ISSUED AND THE SECURITIES PURCHASE AGREEMENT REGARDING 1,000 SHARES OF COMMON STOCK TO BE ISSUED IN THE FORM 8-K FILED WITH THE SEC ON MAY 18, 2020.
false
0
0
0
0
false
NovaBay Pharmaceuticals, Inc.
JUSTIN M. HALL
JUSTIN M. HALL
PRESIDENT, CHIEF EXECUTIVE OFFICER AND GENERAL COUNSEL
2020-05-21